ERBB2 and breast cancer: Moreover, in carcinoma tissues, IL-33 expression is significantly higher in HER2-overexpressing tissues, consistent with the report that its receptor sST2 is over-expressed to promote BC metastases upon ErbB2 activation in BC cell lines (23).